Health data from medical devices and electronic health records remains frustratingly siloed beyond the reach of individuals and analytical tools. Anna McCollister-Slipp, co-founder of a real-time analytics platform, is working to change that.
Patients want it. Innovators want it. Providers want it. What is it? Data, liberated from electronic health records, and medical devices. Not to mention millions of records and documents still trapped in paper form.
Getting this data into a form where it can be browsed, analyzed, and applied to a thousand new theories about disease and treatment is no small feat. Doing it while the healthcare system as we know it is being reinvented is even more challenging.
In the past, I've written about the e-patient movement, healthcare hackers, and how innovation happens. I've talked with some of the leading innovators and the pioneers working on health information exchanges.
When talented individuals bring their passion to more than one of these callings, they can really make an impact. One such individual is Anna McCollister-Slipp. First, she's an innovator. McCollister-Slipp is co-founder of Galileo Analytics, whose Galileo Cosmos visual data exploration and real-time analytics platform was used in a March 2013 demonstration by the American Society of Clinical Oncology (ASCO) to visually explore complex data in ASCO's CancerLinQ prototype.
But McCollister-Slipp has a special stake in this work. She's also a type 1 diabetes patient, with complications.